CD19 and rheumatoid arthritis: Although the decrease in the percentage of CD19+CD5−TLR10+ B cells observed in the RA subjects was not prominent compared to that in the HCs, the TLR10 levels greatly increased with disease activity in the RA subjects (P = 0.033) (Table 2 and Figure 5(b)).